Envestnet Asset Management
NEXI

Envestnet Asset Management’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Envestnet Asset Management’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,257
Closed -$22.9K – 4188
2023
Q2 		$22.9K Hold
3,257
– – ﹤0.01% 3919
2023
Q1 		$30.9K Buy
+3,257
New +$34.2K ﹤0.01% 3900

Other funds holding NEXI

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Envestnet Asset Management's NEXI Position: Q3 2023 in Review

Envestnet Asset Management sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2023, closing a stake of 3,257 shares — an estimated $22.9K sold.

Envestnet Asset Management first reported a position in NEXI in Q1 2023 and held it in 2 quarters. The position peaked at $30.9K in Q1 2023. 30 funds tracked by Wall St. Rank hold NEXI as of Q3 2023.

  • Envestnet Asset Management reported no remaining NexImmune, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 3,257 NexImmune, Inc. Common Stock shares in Q3 2023, an estimated $22.9K.
  • Envestnet Asset Management first reported a position in NexImmune, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • Envestnet Asset Management's NexImmune, Inc. Common Stock position peaked at $30.9K in Q1 2023.
  • 30 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2023.

Based on Envestnet Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.